1. MTHFR C677T polymorphism is associated with methotrexate-induced myelopathy risk. (7th February 2017) Authors: Juster-Switlyk, Kelsey; Smith, A. Gordon; Kovacsovics, Tibor; Stephens, Deborah; Glenn, Martha; Palmer, Cheryl Ann; Quigley, Edward P.; Kolb, Noah Journal: Neurology Issue: Volume 88:Number 6(2017) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. MTHFR C677T polymorphism is associated with methotrexate-induced myelopathy risk. (7th February 2017) Authors: Juster-Switlyk, Kelsey; Smith, A. Gordon; Kovacsovics, Tibor; Stephens, Deborah; Glenn, Martha; Palmer, Cheryl Ann; Quigley, Edward P.; Kolb, Noah Journal: Neurology Issue: Volume 88:Number 6(2017) Page Start: 603 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗